CLINICAL_TRIALS
trial_result
· 2013-10-16
Clinical Trial Update: Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent [Phase 3]
Summary
A completed Phase 3 trial update for Medtronic assessing concomitant radiofrequency use in atrial fibrillation (CURE-AF/Persistent).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medtronic Cardiac Surgery | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2013-10-16